Epic Bio

Epicrispr Biotechnologies

South San Francisco, United States · Founded 2018 · $123.0M raised

Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$123.0M
Last Round
$68.0M Series BMar 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Epicrispr Biotechnologies develops therapies that dynamically control gene expression to treat complex disease by leveraging the epigenome, the ubiquitous system in mammalian cells that controls gene activity. The company describes its approach as working a level above the genome and says it can regulate any gene. Its Gene Expression Modulation System, or GEMS, is a mix-and-match platform that combines epigenomic modulators into therapies customized for specific disease indications.

Summary

Epic Bio is a Biotech company based in South San Francisco, United States, founded in 2018. It has raised $123.0M in total across 2 rounds, most recently a $68.0M Series B round in Mar 2025. Investors include Ally Bridge Group, Horizons Ventures and Solve FSHD.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMar 2025
$68.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Epic Bio on Indexed.vc
<a href="https://indexed.vc/companies/epic-bio"><img src="https://indexed.vc/api/badge/company/epic-bio" alt="Epic Bio on Indexed.vc" width="260" height="76" /></a>